Documentos relacionados

1. Global access to affordable direct oral anticoagulants.
2. Specific Antidotes for Direct Oral Anticoagulant Reversal: Case Closed or Cold Case?
3. [The cost of pulmonary thromboembolism treatment].
4. Are direct oral anticoagulants an economically attractive alternative to low molecular weight heparins in lung cancer associated venous thromboembolism management?
5. Modeling patients' time, travel, and monitoring costs in anticoagulation management: societal savings achievable with the shift from warfarin to direct oral anticoagulants.
6. Estimation of clinical and economic effects of prophylaxis against venous thromboembolism in medical patients, including the effect of targeting patients at high-risk.
7. Cost-effectiveness of anticoagulants for suspected heparin-induced thrombocytopenia in the United States.
8. [Alternatives to heparin and protamine anticoagulation for cardiopulmonary bypass in cardiac surgery].
9. A Review of Two Heparin Prophylaxes for Trauma.
10. Prophylactic anticoagulation after minimally invasive hysterectomy for endometrial cancer: a cost-effectiveness analysis.